LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 48.36 | 17.25 | 4942 | 4390 | 1.1256 | 1.0298 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 48.36 | 17.25 | 82 | 4390 | 0.0187 | 0.2154 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 48.36 | 17.25 | 5188 | 4390 | 1.1817 | 1.0422 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 50.33 | 17.25 | 65 | 4651 | 0.0140 | 0.1785 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 50.33 | 17.25 | 5286 | 4651 | 1.1365 | 1.0319 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 50.33 | 17.25 | 76 | 4651 | 0.0163 | 0.2016 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 50.33 | 17.25 | 5534 | 4651 | 1.1898 | 1.0435 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.30 | 17.25 | 70 | 4798 | 0.0146 | 0.1883 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.30 | 17.25 | 5712 | 4798 | 1.1904 | 1.0434 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.30 | 17.25 | 76 | 4798 | 0.0158 | 0.2004 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.30 | 17.25 | 5845 | 4798 | 1.2181 | 1.0492 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 54.27 | 17.25 | 75 | 4884 | 0.0154 | 0.1977 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 54.27 | 17.25 | 6300 | 4884 | 1.2899 | 1.0635 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 54.27 | 17.25 | 86 | 4884 | 0.0176 | 0.2180 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 54.27 | 17.25 | 6432 | 4884 | 1.3169 | 1.0688 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 56.24 | 17.25 | 64 | 4929 | 0.0130 | 0.1743 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 56.24 | 17.25 | 6937 | 4929 | 1.4074 | 1.0855 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 56.24 | 17.25 | 84 | 4929 | 0.0170 | 0.2141 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 56.24 | 17.25 | 7127 | 4929 | 1.4459 | 1.0925 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 17.25 | 74 | 4942 | 0.0150 | 0.1953 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 17.25 | 7645 | 4942 | 1.5468 | 1.1098 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 17.25 | 91 | 4942 | 0.0184 | 0.2260 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 17.25 | 7629 | 4942 | 1.5436 | 1.1092 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.18 | 17.25 | 54 | 5031 | 0.0107 | 0.1495 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.18 | 17.25 | 8051 | 5031 | 1.6001 | 1.1182 | MN20160310_N02 | E16 |